Abstract

This position paper replaces the previous 2006 WHO position paper on tetanus toxoid (TT) vaccines.It incorporates recent developments in the field of tetanus prevention and provides revised guidance on the optimal timing of recommended tetanus vaccine booster doses. Recommendations on the use of TT-containing vaccines (TTCVs) were discussed by SAGE in October 2016; evidence presented at the meeting can be accessed at: http://www.who.int/immunization/sage/meetings/2016/october/presentations_background_docs/en/

  • Position paper
  • Tetanus